SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-004525
Filing Date
2021-04-15
Accepted
2021-04-15 16:37:29
Documents
12
Period of Report
2021-04-14
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_041421.htm   iXBRL 8-K 190432
  Complete submission text file 0001387131-21-004525.txt   375358

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE admp-20210414.xsd EX-101.SCH 3226
3 XBRL LABEL FILE admp-20210414_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE admp-20210414_pre.xml EX-101.PRE 22737
5 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_041421_htm.xml XML 3627
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 21828936
SIC: 2834 Pharmaceutical Preparations